IL97801A0 - Oligonucleotides,methods for in vitro tissue cell culture using the same and cosmetic compositions containing the same - Google Patents

Oligonucleotides,methods for in vitro tissue cell culture using the same and cosmetic compositions containing the same

Info

Publication number
IL97801A0
IL97801A0 IL97801A IL9780191A IL97801A0 IL 97801 A0 IL97801 A0 IL 97801A0 IL 97801 A IL97801 A IL 97801A IL 9780191 A IL9780191 A IL 9780191A IL 97801 A0 IL97801 A0 IL 97801A0
Authority
IL
Israel
Prior art keywords
same
oligonucleotides
methods
cell culture
compositions containing
Prior art date
Application number
IL97801A
Original Assignee
American Nat Red Cross
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Nat Red Cross filed Critical American Nat Red Cross
Publication of IL97801A0 publication Critical patent/IL97801A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/606Nucleosides; Nucleotides; Nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1136Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against growth factors, growth regulators, cytokines, lymphokines or hormones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/069Vascular Endothelial cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0065Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00Structure or type of the nucleic acid
    • C12N2310/30Chemical structure
    • C12N2310/32Chemical structure of the sugar
    • C12N2310/3212'-O-R Modification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • Vascular Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL97801A 1990-04-09 1991-04-09 Oligonucleotides,methods for in vitro tissue cell culture using the same and cosmetic compositions containing the same IL97801A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US50568190A 1990-04-09 1990-04-09
US57849090A 1990-09-06 1990-09-06

Publications (1)

Publication Number Publication Date
IL97801A0 true IL97801A0 (en) 1992-06-21

Family

ID=27055219

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97801A IL97801A0 (en) 1990-04-09 1991-04-09 Oligonucleotides,methods for in vitro tissue cell culture using the same and cosmetic compositions containing the same

Country Status (7)

Country Link
EP (1) EP0527790A4 (en)
AU (1) AU7676191A (en)
CA (1) CA2080336A1 (en)
IE (1) IE911160A1 (en)
IL (1) IL97801A0 (en)
PT (1) PT97278A (en)
WO (1) WO1991015226A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3129993A (en) * 1991-11-08 1993-06-07 Massachusetts Institute Of Technology Localized oligonucleotide therapy
IL105741A0 (en) * 1992-05-22 1993-09-22 Genta Inc Pharmaceutical compositions for treating cellular hyperproliferation using interleukin-1 inhibitory compounds
AU2735297A (en) * 1996-04-18 1997-11-19 Geron Corporation Senescence responsive transcriptional element
ES2281112T3 (en) 1996-12-26 2007-09-16 Kyowa Hakko Kogyo Co., Ltd. PROTEIN PRESENTING AN AGING SUPPRESSION ACTIVITY.
EA023680B1 (en) * 2009-03-17 2016-06-30 Общество С Ограниченной Ответственностью "Сенгара" Interleukin-1 beta in cosmetic compositions and methods for use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4806463A (en) * 1986-05-23 1989-02-21 Worcester Foundation For Experimental Biology Inhibition of HTLV-III by exogenous oligonucleotides
EP0460052B1 (en) * 1989-02-27 1998-04-15 New England Medical Center Il-1 biological activity inhibitors

Also Published As

Publication number Publication date
IE911160A1 (en) 1991-10-09
PT97278A (en) 1992-01-31
AU7676191A (en) 1991-10-30
EP0527790A1 (en) 1993-02-24
EP0527790A4 (en) 1993-09-15
WO1991015226A1 (en) 1991-10-17
CA2080336A1 (en) 1991-10-10

Similar Documents

Publication Publication Date Title
HK8395A (en) Human factor VIII, compositions containing it, methods and materials for use in its production
CA2347979A1 (en) Treatment of skin with adenosine or adenosine analog
EP0257444A3 (en) Tercopolymers, their use in hair treatment compositions and hair treatment compositions containing them
GB8928179D0 (en) Dna,constructs,cells and plants derived therefrom
AU5790890A (en) Hair growth composition
EP0954564A4 (en) Methods for generating cytotoxic t cells in vitro
GB9009307D0 (en) Dna,constructs,cells and plant derived therefrom
GB8923716D0 (en) Dna,constructs,cells and plants derived therefrom
GB9311276D0 (en) Well inserts for use in tissue culture
IL99135A0 (en) Corticoid-17-alkylcarbonates substituted in the 17-position,process for their preparation and pharmaceutcals containing them
NZ305571A (en) Cryptophycin derivatives, use in pharmaceutical compositions to inhibit mammalian cell proloferation and treat neoplasia
EP1185555A4 (en) Compositions isolated from skin cells and methods for their use
GB9027616D0 (en) Dna,dna constructs,cells and plants derived therefrom
AU4378996A (en) Cell compositions for use in transplantation and ex vivo gene therapy
IL100953A0 (en) Lyophilized mammalian sperm cell compositions and methods for the preparation thereof
GB9018612D0 (en) Dna,constructs,cells and plants derived therefrom
EP0248656A3 (en) Composition for cell cultivation and use thereof
IL97801A0 (en) Oligonucleotides,methods for in vitro tissue cell culture using the same and cosmetic compositions containing the same
EP0437026A3 (en) Use of tandospirone in the treatment of depression
EP0452894A3 (en) Human cells for the high expression of genes inserted in episomal recombinant dna, their preparation and their use
AU7793791A (en) Pharmaceutical composition for use in treating pain
EP0465936A3 (en) Decalinylketones, their use in perfumery and process for their preparation
AU7252391A (en) Device for subcutaneous introduction, in particular for the implantation of artificial hairs
IL121407A0 (en) Substituted indanylidineacetylguanidines process for their preparation their use as medicaments or in diagnosis and medicaments containing them
EP0491472A3 (en) Hair cosmetic composition in gel state